检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王新保[1] 杨镇[1] 李德旭[1] 邓小荣[1] 李大鹏[1] 裘法祖[1]
机构地区:[1]华中科技大学同济医学院附属同济医院普外科,武汉市430035
出 处:《中华肝胆外科杂志》2002年第1期28-30,共3页Chinese Journal of Hepatobiliary Surgery
基 金:国家自然科学基金资助项目 (项目编号 :39470 6 85 )
摘 要:目的 研究门静脉高压症病人肝组织内血管及肝窦壁内皮细胞的凋亡及其对肝微循环的影响。方法 对 37例门静脉高压症病人、10例正常人肝组织 ,用TUNEL法检测血管内皮细胞及肝窦壁内皮细胞凋亡 ,免疫组化法检测Bax和Bcl 2基因的蛋白表达。结果 肝硬化门静脉高压症病人 ,门管区血管内膜破坏、断裂 ,内皮细胞脱落。管腔内血栓形成。血管壁和肝窦壁内皮细胞TUNEL 阳性细胞数为 (2 9 2 9± 4 15 ) % ,与对照组仅 (0 5± 0 2 ) % ,有显著性差异 (P <0 0 0 1) ;门管区血管内皮细胞和肝窦壁内皮细胞Bax和Bcl 2强阳性表达率分别为 (33 5 1± 5 6 9) %和 (2 4 6 4± 5 87) % ,对照组均为阴性 (P <0 0 0 1)。结论 肝硬化门静脉高压症病人门管区内皮细胞和肝窦壁内皮细胞凋亡和坏死明显增加 ,内皮细胞的凋亡和坏死激活凝血系统 ,促使血栓形成 ,从而破坏了肝脏微循环。Objective To investigate the intrahepatic vascular and hepatic sinusoidal endothelial cell (SEC) apoptosis and its influence on hepatic microcirculation in patients with portal hypertension. Methods The apoptosis of VECs and hepatic SECs was examined with TUNEL. The expression of Bax and Bcl 2 protein was analyzed by immunohistochemical technique in 37 cases of portal hypertension and 10 normal individuals. Results Vascular endothelial membrane of portal hypertension show destruction, cleavage and dropout accompanying with thrombosis in the vascular cavity. TUNEL positive cells of VECs and hepatic SECs were (29 29±4 15)% in patients with portal hypertension but only (0 5±0 2)% in normal controls. There was significant difference between the two groups (P<0 001). The Bax and Bcl 2 immunostaining-positive cells were (33 51±5 69)% and (24 64±5 87)% in the patients and normal controls, respectively. Bax was markedly higher than Bcl 2 (P<0 001). Conclusions Apoptosis and necrosis of VECs and SECs occur in portal area in patients with portal hypertension, which activates the blood coagulation system, promotes thrombosis and destroys hepatic microcirculation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.171